Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

Notice to the media - National Advisory Committee on Immunization to provide a technical briefing


OTTAWA, ON, March 15, 2021 /CNW/ - National Advisory Committee on Immunization (NACI) and Government of Canada officials will provide a technical briefing for media on NACI's updated guidance on COVID-19 vaccines.

Officials will be available to answer questions from the media following their remarks.

Date
March 16, 2021

Time
9:00 AM (EDT)

Location

The event will be held on Zoom.

Zoom Link: https://ca01web.zoom.us/j/68331020796
Passcode: 205458

To obtain the briefing package, please RSVP by email at
[email protected].

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: